Basic Investigation| Volume 364, ISSUE 1, P76-87, July 2022

Berberis integerrima hydro-alcoholic root extract and its constituent berberine protect against cisplatin-induced nephro- and hepato-toxicity



      This study determined the potential hepato- and renal protective role of berberine and hydroalcohol extract of Berberis integerrima (barberry) against cisplatin-induced acute liver and kidney injury.


      Animals were dedicated into six groups (n = 7 per group): control, control+Ber (berberine, 0.4 mg/kg/day during 10 days, i.p.), control+B.E (barberry extract, 160 mg/kg/day during 10 days, i.p.), Cis (cisplatin, 8 mg/kg on 7th day, i.p.), Cis+Ber (berberine, 100 mg/kg/day during 10 days; cisplatin, 8 mg/kg on 7th day), Cis+B.E (barberry extract, 160 mg/kg/day during 10 days; cisplatin, 8 mg/kg on 7th day). After placing the rats in metabolic cages for 24 h, blood, urine, liver and kidney tissue samples were collected.


      Compared to control, control+Ber and control+B.E groups, cisplatin administration led to kidney and liver dysfunction. These happened with diminished activities of antioxidant enzymes, increased levels of malondialdehyde, Toll-like receptor 4 gene expression and histological damages in hepatic and renal tissues. Berberine and barberry extract administration decreased all the changes.


      An intensification in enzymatic oxidant status, decrease in lipid peroxidation with decrease in TLR4 gene expression level indicate that barberry extract may be a potential candidate in combating cisplatin-induced oxidative stress and inflammation in liver and kidney tissues through its constituent berberine.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Desoize B.
        • Madoulet C.
        Particular aspects of platinum compounds used at present in cancer treatment.
        Crit Rev Oncol Hematol. 2002; 42: 317-325
        • Cersosimo R.J.
        Hepatotoxicity associated with cisplatin chemotherapy.
        Ann Pharmacother. 1993; 27: 438-441
        • Arany I.
        • Safirstein R.L.
        Cisplatin nephrotoxicity.
        Semin Nephrol. 2003; 23: 460-464
        • Mir M.
        • Arab M.R.
        • Shahraki M.R.
        • et al.
        Toxic effects of cisplatin on hepatocytes and liver enzymes of rats.
        Anat Sci J. 2015; 12 (Original): 171-176
        • Pratibha R.
        • Sameer R.
        • Rataboli P.V.
        • et al.
        Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats.
        Eur J Pharmacol. 2006; 532 (Feb 27): 290-293
        • Dasari S.
        • Tchounwou P.B.
        Cisplatin in cancer therapy: molecular mechanisms of action.
        Eur J Pharmacol. 2014; 740 (Oct 5): 364-378
        • El-Shitany N.A.
        • Eid B.
        Proanthocyanidin protects against cisplatin-induced oxidative liver damage through inhibition of inflammation and NF-κβ/TLR-4 pathway.
        Environ Toxicol. 2017; 32: 1952-1963
        • Zhang B.
        • Ramesh G.
        • Uematsu S.
        • et al.
        TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.
        J Am Soc Nephrol. 2008; 19: 923-932
        • Omar H.A.
        • Mohamed W.R.
        • Arab H.H.
        • et al.
        Tangeretin alleviates cisplatin-induced acute hepatic injury in rats: targeting MAPKs and apoptosis.
        PLoS One. 2016; 11e0151649
        • Mansour H.H.
        • Hafez H.F.
        • Fahmy N.M.
        Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats.
        J Biochem Mol Biol. 2006; 39: 656-661
        • Mohamadi Yarijani Z.
        • Godini A.
        • Madani S.H.
        • et al.
        Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract.
        Biomed Pharmacother. 2018; 106: 1767-1774
        • Rezaeian S.
        • Pourianfar H.R.
        • Janpoor J.
        Antioxidant properties of several medicinal plants growing wild in northeastern Iran.
        Asian J Plant Sci. 2015; 5: 63-68
        • Amiri M.S.
        • Joharchi M.R.
        • Taghavizadehyazdi M.E.
        Ethno-medicinal plants used to cure jaundice by traditional healers of Mashhad, Iran.
        Iran J Pharm Res. 2014; 13: 157-162
        • Chen X.W.
        • Di Y.M.
        • Zhang J.
        • et al.
        Interaction of herbal compounds with biological targets: a case study with berberine.
        Sci World J. 2012; 2012708292
        • Imanshahidi M.
        • Hosseinzadeh H.
        Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.
        Phytother Res. 2008; 22: 999-1012
        • Domitrovic R.
        • Jakovac H.
        • Blagojevic G.
        Hepatoprotective activity of berberine is mediated by inhibition of TNF-alpha, COX-2, and iNOS expression in CCl(4)-intoxicated mice.
        Toxicology. 2011; 280: 33-43
        • Rezaee-Khorasany A.
        • Razavi B.M.
        • Taghiabadi E.
        • al T.
        Effect of saffron (stigma of Crocus sativus L.) aqueous extract on ethanol toxicity in rats: a biochemical, histopathological and molecular study.
        J Ethnopharmacol. 2019; 237: 286-299
        • Hosseinzadeh H.
        • Ramezani M.
        • Shafaei H.
        • et al.
        Anticonvulsant effect of Berberis integerrima L. root extracts in mice.
        J Acupunct Meridian Stud. 2013; 6: 12-17
        • Zheng H.
        • Lan J.
        • Li J.
        • et al.
        Therapeutic effect of berberine on renal ischemia-reperfusion injury in rats and its effect on Bax and Bcl-2.
        Exp Ther Med. 2018; 16 (2018/09/01): 2008-2012
        • Heath R.
        • Packer L.
        Photoperoxidation in isolated chloroplast.I. Kinetics and stoichiometry of fatty acid peroxidation.
        J Biochem Biophs. 1986; 125: 189-190
        • Ighodaro O.M.
        • Akinloye O.A.
        First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid.
        Alex J Med. 2017;
        • Misra H.P.
        • Fridovich I.
        The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.
        J Biol Chem. 1972; 247: 3170-3175
        • Aebi H.
        Catalase in vitro.
        Methods Enzymol. 1984; 105: 121-126
        • Livak K.J.
        • Schmittgen T.D.
        Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
        Methods. 2001; 25: 402-408
        • Gholampour F.
        • Saki N.
        Hepatic and renal protective effects of quercetin in ferrous sulfate induced toxicity.
        Gen Physiol Biophys. 2019; 38: 27-38
        • Gholampour F.
        • Mohammadi Z.
        • Karimi Z.
        • et al.
        Protective effect of genistein in a rat model of ischemic acute kidney injury.
        Gene. 2020; : 753
        • Gholampour F.
        • Bagheri A.
        • Barati A.
        • et al.
        Remote ischemic perconditioning modulates apelin expression after renal ischemia-reperfusion injury.
        J Surg Res. 2020; 247: 429-437
        • Ingawale D.K.
        • Mandlik S.K.
        • Naik S.R.
        Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion.
        Environ Toxicol Pharmacol. 2014; 37: 118-133
        • Rahimi-Madiseh M.
        • Gholami-Arjenaki M.
        • Bahmani M.
        • et al.
        Evaluation of minerals, phenolics and anti-radical activity of three species of Iranian berberis fruit.
        Der Pharma Chem. 2016; 8: 191-197
        • Zhu X.
        • Guo X.
        • Mao G.
        • et al.
        Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1.
        Phytother Res. 2013; 27: 417-421
        • Sheng M.
        • Zhou Y.
        • Yu W.
        • et al.
        Protective effect of Berberine pretreatment in hepatic ischemia/reperfusion injury of rat.
        Transplant Proc. 2015; 47: 275-282
        • Li Z.
        • Geng Y.N.
        • Jiang J.D.
        • et al.
        Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.
        Evid Based Complement Altern Med. 2014; 2014289264
        • Sun Y.
        • Yang J.
        • Wang L.Z.
        • et al.
        Crocin attenuates cisplatin-induced liver injury in the mice.
        Hum Exp Toxicol. 2014; 33: 855-862
        • Verma P.K.
        • Raina R.
        • Sultana M.
        • et al.
        Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn.
        Ren Fail. 2016; 38: 142-150
        • Kaltalioglu K.
        • Balabanli B.
        • Coskun-Cevher S.
        Alleviation of cisplatin-induced hepatotoxic damage: the synergistic effect of morin and hesperidin against oxidative stress.
        Res J Pharmacogn. 2019; 6: 9-18
        • Ma X.
        • Yan L.
        • Zhu Q.
        • et al.
        Puerarin attenuates cisplatin-induced rat nephrotoxicity: the involvement of TLR4/NF-kappaB signaling pathway.
        PLoS One. 2017; 12e0171612
        • Sen S.
        • Chakraborty R.
        • Kalita P.
        Dillenia indica fruit prevents cisplatin-induced kidney injury in experimental rats through modulation of oxidative stress, marker enzyme, and biochemical changes.
        Nutrire. 2018; 43
        • Maheshwari R.A.
        • Sailor G.U.
        • Sen A.K.
        • et al.
        Amelioration of cisplatin-induced hepatotoxicity by statins in rats.
        JIHS. 2015; 3: 21-27
        • Lu Y.
        • Cederbaum A.I.
        Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1.
        Toxicol Sci. 2006; 89: 515-523
        • Al-Malki A.L.
        • Sayed A.A.
        Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β.
        BMC Complement Altern Med. 2014; 14: 282-290
        • Santos N.A.
        • Catão C.S.
        • Martins N.M.
        • et al.
        Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
        Arch Toxicol. 2007; 81: 495-504
        • Satoh M.
        • Kashihara N.
        • Fujimoto S.
        • et al.
        A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.
        J Pharmacol Exp Ther. 2003; 305: 1183-1190
        • Singh J.
        • Kakkar P.
        Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats.
        J Ethnopharmacol. 2009; 123: 22-26
        • Fatehi M.
        • Saleh T.M.
        • Fatehi-Hassanabad Z.
        • et al.
        A pharmacological study on Berberis vulgaris fruit extract.
        J Ethnopharmacol. 2005; 102 (2005/10/31/): 46-52
        • Zovko Koncić M.
        • Kremer D.
        • Karlović K.
        • et al.
        Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat.
        Food Chem Toxicol. 2010; 48: 2176-2180
        • Suau R.
        • Rico R.
        • López-Romero J.M.
        • et al.
        Isoquinoline alkaloids from Berberis Vulgaris subsp. Australis.
        Phytochemistry. 1998; 49 (1998/12/20/): 2545-2549
        • Chirino Y.I.
        • Hernandez-Pando R.
        • Pedraza-Chaverri J.
        Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats.
        BMC Pharmacol. 2004; 4: 20
        • Lee C.K.
        • Park K.K.
        • Lim S.S.
        • et al.
        Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer.
        Biol Pharm Bull. 2007; 30: 2191-2195
        • Alhadeff A.L.
        • Holland R.A.
        • Zheng H.
        • et al.
        Excitatory hindbrain-forebrain communication is required for cisplatin-induced anorexia and weight loss.
        J Neurosci. 2017; 37: 362-370
        • Shahid F.
        • Farooqui Z.
        • Khan F.
        Cisplatin-induced gastrointestinal toxicity: an update on possible mechanisms and on available gastroprotective strategies.
        Eur J Pharmacol. 2018; 827: 49-57
        • Wang K.
        Molecular mechanisms of hepatic apoptosis.
        Cell Death Dis. 2014; 5: e996
        • Chirino Y.I.
        • Pedraza-Chaverri J.
        Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
        Exp Toxicol Pathol. 2009; 61 (2009/05/01/): 223-242
        • Pulskens W.P.
        • Rampanelli E.
        • Teske G.J.
        • et al.
        TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury.
        J Am Soc Nephrol. 2010; 21: 1299-1308
        • Guo Y.
        • Wang M.
        • Mou J.
        • et al.
        Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity.
        Sci Rep. 2018; 8: 7333
        • Zhang B.
        • Ramesh G.
        • Norbury C.C.
        • et al.
        Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.
        Kidney Int. 2007; 72: 37-44
        • Oh G.S.
        • Kim H.J.
        • Shen A.
        • et al.
        Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies.
        Electrolyte Blood Press. 2014; 12: 55-65
        • Kribben A.
        • Edelstein C.L.
        • Schrier R.W.
        Pathophysiology of acute renal failure.
        J Nephrol. 1999; 2: S142-S151
        • Fateh S.
        • Dibazar S.P.
        • Daneshmandi S.
        Barberry's (Berberis integerrima) ingredients suppress T-cell response and shift immune responses toward Th2: an in vitro study.
        Future Sci OA. 2015; 1 (FSO49-FSO49)